Dextech Medical AB (NGM: DEX)

Dextech Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	19.04	19.04	25.24	35.47	3.46	6.09
Cash & Short-Term Investments	19.04	19.04	25.24	35.47	3.46	6.09
Cash Growth	-24.54%	-24.54%	-28.86%	926.20%	-43.25%	53887.79%
Accounts Receivable	0.64	0.64	-	-	-	-
Other Receivables	-	-	0.11	0.2	0.03	0.03
Receivables	0.64	0.64	0.11	0.2	0.03	0.03
Other Current Assets	-	-	0.47	0.35	0.26	0.25
Total Current Assets	19.68	19.68	25.82	36.02	3.75	6.37
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	10.91	10.91	0.25	0.39	0.54	0.51
Long-Term Deferred Charges	-	-	8.97	3.18	2.94	6.46
Total Assets	30.59	30.59	35.03	39.59	7.23	13.34
Accounts Payable	-	-	0.15	0.25	0.04	0.07
Accrued Expenses	-	-	0.55	0.43	0.15	0.15
Other Current Liabilities	0.98	0.98	0.02	0.03	0.03	0.03
Total Current Liabilities	0.98	0.98	0.72	0.71	0.22	0.25
Total Liabilities	0.98	0.98	0.72	0.71	0.22	0.25
Common Stock	29.61	29.61	0.83	0.83	0.67	0.67
Additional Paid-In Capital	-	-	105.2	105.2	68.22	68.22
Retained Earnings	-	-	-71.71	-67.15	-61.88	-55.8
Shareholders' Equity	29.61	29.61	34.31	38.88	7.02	13.09
Total Liabilities & Equity	30.59	30.59	35.03	39.59	7.23	13.34
Net Cash (Debt)	19.04	19.04	25.24	35.47	3.46	6.09
Net Cash Growth	-24.54%	-24.54%	-28.86%	926.20%	-43.25%	53887.79%
Net Cash Per Share	1.03	1.03	1.37	2.09	0.23	0.41
Filing Date Shares Outstanding	18.49	18.49	18.49	18.49	14.92	14.92
Total Common Shares Outstanding	18.49	18.49	18.49	18.49	14.92	14.92
Working Capital	18.7	18.7	25.1	35.31	3.54	6.12
Book Value Per Share	1.60	1.60	1.86	2.10	0.47	0.88
Tangible Book Value	18.7	18.7	34.07	38.49	6.47	12.58
Tangible Book Value Per Share	1.01	1.01	1.84	2.08	0.43	0.84

Source: S&P Capital IQ. Standard template. Financial Sources.